Lifshitz Law PLLC Announces Investigations of Lisata Therapeutics, Inc. (Nasdaq: LSTA), RAPT Therapeutics, Inc. (Nasdaq: RAPT), Mission Produce, Inc. (Nasdaq: AVO), and Allegiant Travel Company (Nasdaq: ALGT)

NEW YORK CITY, NY / ACCESS Newswire / February 11, 2026 / Lisata Therapeutics, Inc. (Nasdaq:LSTA)

Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the acquisition of LSTA by Kuva Labs, Inc. ("Kuva"). Under the terms of the term sheet, Kuva will commence a tender offer to purchase all of the outstanding shares of common stock of LSTA for $4.00 per share in cash. Additionally, LSTA stockholders will be entitled to receive two non-tradeable contingent value rights (CVRs), payable as follows: (i) $1.00 per share, in cash, within 12 months of the date on which rights to certepetide in the Greater China region revert to LSTA from Qilu Pharmaceutical and (ii) $1.00 per share, in cash, upon the filing of an NDA or similar registration document by Kuva for approval to commercialize certepetide in any indication in any jurisdiction.

The $4.00 per share cash offer price represents an approximate 85% premium and, including both CVRs, an approximate 180% premium to LSTA's most recent closing stock price.

If you are an LSTA investor and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

RAPT Therapeutics, Inc. (Nasdaq:RAPT)

Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the acquisition of RAPT by GSK plc ("GSK"). Under the terms of the transaction agreement, acquisition includes ozureprubart, a potentially best-in-class anti-IgE antibody, in development for prophylactic protection against food allergens. Upon closing, RAPT shareholders RAPT stockholders are expected to receive $58.00 per share in cash.

The consideration represents an estimated aggregate equity value of $2.2 billion. Net of cash acquired, GSK's estimated upfront investment is $1.9 billion.

If you are an RAPT investor and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Mission Produce, Inc. (Nasdaq:AVO)

Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with AVO's acquisition of Calavo Growers, Inc. ("Calavo"). Under the terms of the transaction agreement, Calavo stockholders are expected to receive $27.00 per share comprised of: (i) $14.85 in cash and (ii) 0.9790 shares of AVO for each share of Calavo.

Upon completion of the transaction, AVO and Calavo shareholders are expected to own 80.3% and 19.7%, respectively, of the combined company. The transaction values Calavo at a total enterprise value of approximately $430 million.

If you are an AVO investor and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Allegiant Travel Company (Nasdaq:ALGT)

Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with ALGT's acquisition of Sun Country Airlines ("Sun Country"). Under the terms of the transaction agreement, Sun Country shareholders will receive: (i) 0.1557 shares of ALGT common stock and (ii) $4.10 in cash for each Sun Country share owned, representing an implied value of $18.89 per Sun Country share.

The transaction values Sun Country at approximately $1.5 billion, inclusive of $0.4 billion of Sun Country's net debt. Upon completion of the transaction, ALGT and Sun Country shareholders are expected to own approximately 67% and 33%, respectively, of the combined company.

If you are an ALGT investor and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

ATTORNEY ADVERTISING.© 2026 Lifshitz Law PLLC. The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516) 493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.

Lifshitz Law PLLC

Phone: 516-493-9780

Facsimile: 516-280-7376

Email:[email protected]

SOURCE: Lifshitz Law Firm